Dysregulation of immune system and chronic inflammation are among the potential contributors of the development of CKD-aP through numerous mediators including interleukin-2 (IL-2), prostaglandin E2 (PGE2), serotonin, histamine, proteases, and platelet activating factor. Here, IL2 is linked to chronic kidney disease.